| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PYXS
Pyxis Oncology
|
Jul 06, 2026 | BUY |
Strong Buy
+158.8% avg upside
13 analysts
|
$7.00
162.20% Upside
|
+9.3% |
|
ABSI
AbSci
|
Jul 06, 2026 | BUY |
Strong Buy
+14.1% avg upside
18 analysts
|
$16.00
51.01% Upside
|
-8.2% |
|
CANF
Can-Fite BioPharma
|
Jul 02, 2026 | BUY |
Strong Buy
+57.4% avg upside
8 analysts
|
$8.00
146.11% Upside
|
· |
|
HYFT
MindWalk Holdings
|
Jul 02, 2026 | BUY |
Strong Buy
+203.0% avg upside
3 analysts
|
$5.00
249.62% Upside
|
· |
|
INAB
IN8bio
|
Jul 01, 2026 | BUY |
Strong Buy
+4411.3% avg upside
5 analysts
|
$6.00
351.17% Upside
|
-6.3% |
|
IPHA
Innate Pharma
|
Jul 01, 2026 | BUY |
Strong Buy
+265.1% avg upside
10 analysts
|
$5.00
178.90% Upside
|
· |
|
ETON
Eton Pharmaceuticals
|
Jul 01, 2026 | BUY |
Strong Buy
-30.3% avg upside
8 analysts
|
$57.00
55.61% Upside
|
-1.3% |
|
DNTH
Dianthus Therapeutics
|
Jul 01, 2026 | BUY |
Strong Buy
-8.0% avg upside
29 analysts
|
$130.00
33.25% Upside
|
+8.2% |
|
CELC
Celcuity
|
Jul 01, 2026 | BUY |
Strong Buy
+14.7% avg upside
16 analysts
|
$145.00
34.86% Upside
|
+3.0% |
|
NUVL
Nuvalent
|
Jul 01, 2026 | HOLD |
Buy
-0.7% avg upside
21 analysts
|
$124.00
0.01% Upside
|
+0.2% |
|
UNCY
Unicycive Therapeutics
|
Jul 01, 2026 | BUY |
Strong Buy
+921.1% avg upside
10 analysts
|
$15.00
187.89% Upside
|
· |
|
EVAX
Evaxion Biotech
|
Jul 01, 2026 | BUY |
Strong Buy
+297.5% avg upside
6 analysts
|
$16.00
404.82% Upside
|
· |
|
CNXU
Conexeu Sciences, Inc.
|
Jun 22, 2026 | BUY |
Strong Buy
+96.1% avg upside
1 analyst
|
$20.00
96.07% Upside
|
· |
|
MIRM
Mirum Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
-4.0% avg upside
21 analysts
|
$185.00
51.47% Upside
|
+27.4% |
|
HUMA
Humacyte
|
Jun 12, 2026 | BUY |
Strong Buy
+862.2% avg upside
11 analysts
|
$4.00
476.52% Upside
|
-33.6% |
|
ACTU
Actuate Therapeutics, Inc.
|
Jun 10, 2026 | BUY |
Strong Buy
+974.4% avg upside
4 analysts
|
$15.00
1139.70% Upside
|
-23.1% |
|
CGEN
Compugen
|
Jun 04, 2026 | BUY |
Strong Buy
+121.2% avg upside
8 analysts
|
$4.00
67.29% Upside
|
· |
|
CORT
Corcept Therapeutics
|
Jun 02, 2026 | BUY |
Buy
-52.6% avg upside
15 analysts
|
$95.00
3.42% Upside
|
+32.1% |
|
FR:NANO
Nanobiotix
|
Jun 02, 2026 | BUY |
Strong Buy
+68.5% avg upside
1 analyst
|
$60.00
68.54% Upside
|
· |
|
PGEN
Precigen
|
Jun 02, 2026 | BUY |
Strong Buy
+357.4% avg upside
11 analysts
|
$14.00
163.24% Upside
|
+37.8% |
|
MDWD
Mediwound
|
May 28, 2026 | BUY |
Strong Buy
+51.1% avg upside
13 analysts
|
$36.00
151.95% Upside
|
+1.0% |
|
QSI
Quantum-Si
|
May 26, 2026 | BUY |
Strong Buy
+183.2% avg upside
3 analysts
|
$4.00
353.19% Upside
|
-23.4% |
|
LFWD
Lifeward
|
May 26, 2026 | BUY |
Strong Buy
-13.1% avg upside
8 analysts
|
$10.00
19.23% Upside
|
+0.0% |
|
DCTH
Delcath Systems
|
May 26, 2026 | BUY |
Strong Buy
+65.2% avg upside
11 analysts
|
$30.00
130.62% Upside
|
+18.8% |
|
CTXR
Citius Pharmaceuticals
|
May 19, 2026 | BUY |
Strong Buy
+758.0% avg upside
3 analysts
|
$4.00
586.40% Upside
|
· |
|
VOR
Vor Biopharma
|
May 18, 2026 | BUY |
Buy
+126.6% avg upside
17 analysts
|
$31.00
61.95% Upside
|
+42.2% |
|
BSEM
BioStem Technologies
|
May 18, 2026 | BUY |
Strong Buy
+89.7% avg upside
1 analyst
|
$7.00
89.70% Upside
|
· |
|
RNXT
RenovoRx
|
May 14, 2026 | BUY |
Strong Buy
+588.1% avg upside
5 analysts
|
$3.00
222.45% Upside
|
+6.3% |
|
EVO
Evotec AG
|
May 12, 2026 | BUY |
Strong Buy
+256.5% avg upside
9 analysts
|
$7.00
151.32% Upside
|
-4.3% |
|
ALXO
ALX Oncology Holdings
|
May 11, 2026 | BUY |
Strong Buy
+744.4% avg upside
11 analysts
|
$4.00
88.16% Upside
|
+12.0% |
|
JANX
Janux Therapeutics Inc
|
May 11, 2026 | BUY |
Strong Buy
+175.0% avg upside
21 analysts
|
$45.00
174.35% Upside
|
+17.1% |
|
OCGN
Ocugen
|
May 11, 2026 | BUY |
Strong Buy
+529.3% avg upside
17 analysts
|
$10.00
580.29% Upside
|
-0.7% |
|
VCEL
Vericel
|
May 08, 2026 | BUY |
Strong Buy
-2.9% avg upside
16 analysts
|
$70.00
49.03% Upside
|
+40.5% |
|
FOCL
EDAP TMS
|
May 08, 2026 | BUY |
Buy
+27.0% avg upside
7 analysts
|
$10.00
83.93% Upside
|
· |
|
ECOR
Electrocore
|
May 07, 2026 | BUY |
Buy
+582.0% avg upside
10 analysts
|
$18.00
172.99% Upside
|
· |
|
AEMD
Aethlon Medical
|
Feb 17, 2026 | HOLD |
Buy
+2183.4% avg upside
3 analysts
|
$1.50
111.93% Upside
|
+8.5% |
|
CHRN
ChronoScale
|
Dec 31, 2025 | HOLD |
Buy
-54.6% avg upside
4 analysts
|
— | · |
|
CYPH
Cypherpunk Technologies
|
Nov 18, 2025 | HOLD |
Buy
+1148.2% avg upside
9 analysts
|
— | · |
|
PSNL
Personalis
|
Nov 18, 2025 | HOLD |
Strong Buy
-12.3% avg upside
11 analysts
|
— | +84.7% |
|
DYAI
Dyadic International
|
Nov 18, 2025 | HOLD |
Buy
3 analysts
|
— | -23.3% |
|
INTS
Intensity Therapeutics, Inc.
|
Nov 12, 2025 | BUY |
Strong Buy
+1163.9% avg upside
6 analysts
|
$125.00
2515.09% Upside
|
-63.8% |
|
XFOR
X4 Pharmaceuticals
|
Nov 10, 2025 | BUY |
Strong Buy
+441.6% avg upside
16 analysts
|
$5.00
13.48% Upside
|
+21.5% |
|
BCYC
Bicycle Therapeutics
|
Oct 31, 2025 | BUY |
Strong Buy
+449.3% avg upside
20 analysts
|
$33.00
648.36% Upside
|
-47.6% |
|
CLGN
Collplant Holdings
|
Aug 21, 2025 | BUY |
Strong Buy
+4485.6% avg upside
3 analysts
|
$11.00
2889.17% Upside
|
-83.2% |
|
MDAI
Spectral AI
|
Aug 14, 2025 | BUY |
Strong Buy
+161.6% avg upside
3 analysts
|
$3.50
103.41% Upside
|
-10.0% |
|
TSE:MDNA
Medicenna Therapeutics Corp
|
Aug 04, 2025 | BUY |
Strong Buy
+1220.0% avg upside
9 analysts
|
$3.55
860.31% Upside
|
· |
|
AFMDQ
Affimed
|
May 28, 2025 | HOLD |
Buy
+12648900.0% avg upside
15 analysts
|
— | · |
|
AGPU
Axe Compute Inc
|
Nov 15, 2024 | HOLD |
Buy
-59.3% avg upside
2 analysts
|
— | -37.1% |
|
MDXG
MiMedx Group
|
May 01, 2024 | BUY |
Strong Buy
+157.2% avg upside
17 analysts
|
$11.00
167.74% Upside
|
-13.5% |
|
TCRT
Alaunos Therapeutics
|
Apr 02, 2024 | HOLD |
Buy
+638.7% avg upside
13 analysts
|
— | -84.1% |
|
PLUR
Pluri
|
Feb 15, 2024 | HOLD |
Strong Buy
+249.9% avg upside
8 analysts
|
— | -25.0% |
|
CDXS
Codexis
|
Aug 07, 2023 | HOLD |
Strong Buy
+320.3% avg upside
13 analysts
|
— | +21.3% |
|
CELU
Celularity
|
May 25, 2023 | BUY |
Buy
+1971.0% avg upside
6 analysts
|
$25.00
3276.55% Upside
|
-42.8% |
|
CRVO
CervoMed
|
Mar 06, 2023 | HOLD |
Strong Buy
+489.5% avg upside
9 analysts
|
— | +74.0% |
|
PLSE
Pulse Biosciences
|
Mar 06, 2023 | HOLD |
Strong Buy
+16.7% avg upside
5 analysts
|
— | +234.7% |
|
CLRB
Cellectar Biosciences
|
Mar 06, 2023 | HOLD |
Strong Buy
+2928.4% avg upside
7 analysts
|
— | +110.5% |
|
NTBLQ
Notable Labs
|
Mar 06, 2023 | HOLD |
Buy
+809999900.0% avg upside
12 analysts
|
— | -69.2% |
|
CASIF
CASI Pharmaceuticals
|
Aug 15, 2022 | BUY |
Strong Buy
+17359.2% avg upside
5 analysts
|
$12.00
8170.12% Upside
|
· |
|
MESO
Mesoblast
|
Jun 01, 2022 | BUY |
Strong Buy
+60.5% avg upside
14 analysts
|
$16.00
3.71% Upside
|
+1.7% |
|
CRVS
Corvus Pharmaceuticals
|
May 11, 2022 | BUY |
Strong Buy
+63.0% avg upside
14 analysts
|
$6.00
61.74% Downside
|
+84.5% |
|
CARM
Carisma Therapeutics
|
Nov 09, 2021 | HOLD |
Buy
+53081.8% avg upside
11 analysts
|
— | · |
|
FR:AB
AB Science SA
|
Mar 26, 2021 | HOLD |
Buy
+582.0% avg upside
2 analysts
|
— | · |
|
CATX
Perspective Therapeutics
|
Mar 26, 2021 | HOLD |
Strong Buy
+272.8% avg upside
22 analysts
|
— | -66.1% |
|
ZOMDF
Zomedica
|
Jan 29, 2021 | BUY |
Buy
+1279.7% avg upside
3 analysts
|
$1.20
1279.68% Upside
|
-68.5% |
|
M
Macy's
|
Jan 20, 2021 | BUY |
Buy
+143.1% avg upside
35 analysts
|
— | +95.7% |
|
INMB
Inmune Bio
|
Nov 09, 2020 | BUY |
Buy
+537.7% avg upside
11 analysts
|
$15.00
673.17% Upside
|
+100.0% |
|
FR:OSE
OSE Immunotherapeutics SA
|
Mar 27, 2020 | BUY |
Strong Buy
+244.0% avg upside
4 analysts
|
$7.00
107.50% Upside
|
· |
|
VSTM
Verastem
|
Mar 16, 2020 | BUY |
Strong Buy
+171.9% avg upside
24 analysts
|
$2.80
49.46% Downside
|
+38.6% |
|
CTSO
Cytosorbents
|
Mar 06, 2020 | BUY |
Strong Buy
+3017.3% avg upside
13 analysts
|
$13.00
3309.41% Upside
|
+42.8% |
|
ATEC
Alphatec Holdings
|
Mar 06, 2020 | BUY |
Strong Buy
+85.4% avg upside
22 analysts
|
$9.50
0.80% Downside
|
+174.6% |
|
RDHL
RedHill Biopharma
|
Mar 05, 2020 | BUY |
Strong Buy
+2777.7% avg upside
7 analysts
|
$14.00
1914.30% Upside
|
+65.5% |
|
THMO
ThermoGenesis Holdings
|
Nov 21, 2019 | BUY |
Buy
+7499900.0% avg upside
4 analysts
|
$7.50
7499899.98% Upside
|
· |
|
FBRX
Forte Biosciences
|
Nov 14, 2019 | HOLD |
Strong Buy
-7.3% avg upside
14 analysts
|
— | +278.0% |
|
TSE:CSCI
COSCIENS Biopharma
|
Nov 11, 2019 | BUY |
Buy
+113.0% avg upside
8 analysts
|
$6.40
20.96% Downside
|
· |
|
FR:IPH
Innate Pharma SA
|
Oct 02, 2019 | BUY |
Strong Buy
+461.0% avg upside
5 analysts
|
$11.00
598.06% Upside
|
· |
|
ONTO
Onto Innovation
|
Apr 04, 2019 | BUY |
Strong Buy
-22.7% avg upside
16 analysts
|
$28.57
91.17% Downside
|
-21.0% |
|
TARA
Protara Therapeutics
|
Mar 18, 2019 | BUY |
Strong Buy
+1101.8% avg upside
21 analysts
|
$160.00
3603.65% Upside
|
-81.5% |
|
LLY
Eli Lilly & Co
|
Apr 18, 2018 | BUY |
Strong Buy
-13.5% avg upside
47 analysts
|
— | +47.8% |
|
ADYX
Adynxx
|
Jan 08, 2018 | HOLD |
Strong Buy
+338749899.9% avg upside
4 analysts
|
$2.80
279999899.97% Upside
|
· |
|
CLDX
Celldex
|
May 15, 2017 | BUY |
Strong Buy
-0.0% avg upside
28 analysts
|
$6.00
84.69% Downside
|
-77.7% |
|
AGEN
Agenus
|
May 05, 2017 | HOLD |
Strong Buy
+137.1% avg upside
17 analysts
|
$5.00
49.19% Upside
|
-2.6% |
|
KZIA
Kazia Therapeutics
|
Feb 28, 2017 | BUY |
Strong Buy
+83.3% avg upside
7 analysts
|
$20.00
47.43% Upside
|
-27.3% |
|
IMMP
Immutep
|
Feb 28, 2017 | BUY |
Strong Buy
+1188.8% avg upside
7 analysts
|
$7.50
1689.97% Upside
|
-37.9% |
|
CAPR
Capricor Therapeutics
|
Nov 16, 2016 | BUY |
Strong Buy
+131.2% avg upside
12 analysts
|
— | -25.4% |
|
IMNN
Imunon
|
Nov 11, 2016 | BUY |
Strong Buy
+626.1% avg upside
11 analysts
|
$3.00
48.59% Upside
|
-83.6% |
|
XTNT
Xtant Medical Holdings
|
Aug 03, 2016 | BUY |
Strong Buy
+1519.5% avg upside
9 analysts
|
— | -57.8% |
|
RBSH
Rebus Holdings
|
Mar 28, 2016 | BUY |
Strong Buy
+1999900.0% avg upside
2 analysts
|
$2.00
1999900.04% Upside
|
· |
|
XTLB
XTL Biopharmaceuticals Sponsored ADR
|
Mar 22, 2016 | BUY |
Strong Buy
+106.1% avg upside
1 analyst
|
$6.00
106.11% Upside
|
-59.0% |
|
SRNE
Sorrento Therapeutics
|
Dec 07, 2015 | BUY |
Strong Buy
+3571328.5% avg upside
7 analysts
|
$45.00
6428471.41% Upside
|
-34.8% |
|
SSKN
Strata Skin Sciences
|
Aug 24, 2015 | BUY |
Strong Buy
+1499899.9% avg upside
5 analysts
|
$5.00
1249899.93% Upside
|
-38.1% |
|
ALDX
Aldeyra Therapeutics
|
May 14, 2015 | BUY |
Strong Buy
+670.4% avg upside
21 analysts
|
$14.00
576.31% Upside
|
-25.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.